RHHBY
Price
$41.22
Change
+$0.35 (+0.86%)
Updated
Jul 10 closing price
Capitalization
250.69B
13 days until earnings call
RHHVF
Price
$330.45
Change
+$3.67 (+1.12%)
Updated
Jul 10 closing price
Capitalization
250.69B
13 days until earnings call
Interact to see
Advertisement

RHHBY vs RHHVF

Header iconRHHBY vs RHHVF Comparison
Open Charts RHHBY vs RHHVFBanner chart's image
Roche Holding
Price$41.22
Change+$0.35 (+0.86%)
Volume$1.06M
Capitalization250.69B
Roche Holding
Price$330.45
Change+$3.67 (+1.12%)
Volume$132
Capitalization250.69B
RHHBY vs RHHVF Comparison Chart in %
Loading...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBY vs. RHHVF commentary
Jul 11, 2025

To understand the difference between Roche Holding AG - ADR (RHHBY) vs. Roche Holding AG (RHHVF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (RHHBY: $41.22 vs. RHHVF: $330.45)
Brand notoriety: RHHBY and RHHVF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 72% vs. RHHVF: 1%
Market capitalization -- RHHBY: $250.69B vs. RHHVF: $250.69B
RHHBY [@Pharmaceuticals: Major] is valued at $250.69B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 2 FA rating(s) are green whileRHHVF’s FA Score has 2 green FA rating(s).

  • RHHBY’s FA Score: 2 green, 3 red.
  • RHHVF’s FA Score: 2 green, 3 red.
According to our system of comparison, RHHBY is a better buy in the long-term than RHHVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 4 TA indicator(s) are bullish while RHHVF’s TA Score has 7 bullish TA indicator(s).

  • RHHBY’s TA Score: 4 bullish, 5 bearish.
  • RHHVF’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, RHHVF is a better buy in the short-term than RHHBY.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а +1.93% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was +3.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.39%. For the same industry, the average monthly price growth was +1.04%, and the average quarterly price growth was +11.01%.

Reported Earning Dates

RHHBY is expected to report earnings on Oct 23, 2025.

RHHVF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.39% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($251B) and RHHVF($251B) have the same market capitalization . RHHBY (19.46) and RHHVF (19.34) have similar P/E ratio . RHHBY YTD gains are higher at: 22.106 vs. RHHVF (18.017). RHHBY (19.1B) and RHHVF (19.1B) have comparable annual earnings (EBITDA) . RHHBY (7.51B) and RHHVF (7.51B) have equal amount of cash in the bank . RHHBY (25.4B) and RHHVF (25.4B) have identical debt. RHHBY (60B) and RHHVF (60B) have equivalent revenues.
RHHBYRHHVFRHHBY / RHHVF
Capitalization251B251B100%
EBITDA19.1B19.1B100%
Gain YTD22.10618.017123%
P/E Ratio19.4619.34101%
Revenue60B60B100%
Total Cash7.51B7.51B100%
Total Debt25.4B25.4B100%
FUNDAMENTALS RATINGS
RHHBY vs RHHVF: Fundamental Ratings
RHHBY
RHHVF
OUTLOOK RATING
1..100
6177
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
5051
P/E GROWTH RATING
1..100
1717
SEASONALITY SCORE
1..100
4050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (16) in the null industry is in the same range as RHHVF (17). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (78) in the null industry is in the same range as RHHVF (100). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's SMR Rating (99) in the null industry is in the same range as RHHVF (99). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Price Growth Rating (50) in the null industry is in the same range as RHHVF (51). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's P/E Growth Rating (17) in the null industry is in the same range as RHHVF (17). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYRHHVF
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
44%
Bullish Trend 1 day ago
51%
MACD
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 9 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
44%
Bullish Trend 1 day ago
57%
Aroon
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RVYL0.710.03
+4.93%
Ryvyl
NMRA1.060.04
+3.92%
Neumora Therapeutics
CHD99.090.70
+0.71%
Church & Dwight Co
WALD2.57-0.01
-0.39%
Waldencast plc
SBRA18.37-0.13
-0.70%
Sabra Health Care REIT

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+0.86%
RHHVF - RHHBY
65%
Loosely correlated
+1.12%
NVS - RHHBY
37%
Loosely correlated
+0.64%
JNJ - RHHBY
37%
Loosely correlated
+0.90%
RHHBF - RHHBY
32%
Poorly correlated
-2.55%
BMY - RHHBY
28%
Poorly correlated
+1.80%
More

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
+1.12%
RHHBY - RHHVF
65%
Loosely correlated
+0.86%
JNJ - RHHVF
31%
Poorly correlated
+0.90%
NVS - RHHVF
27%
Poorly correlated
+0.64%
AZN - RHHVF
26%
Poorly correlated
+1.40%
RHHBF - RHHVF
25%
Poorly correlated
-2.55%
More